These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 36655588)
21. A multicenter retrospective study on clinical characteristics, treatment patterns, and outcome in elderly patients with hepatocellular carcinoma. Kozyreva ON; Chi D; Clark JW; Wang H; Theall KP; Ryan DP; Zhu AX Oncologist; 2011; 16(3):310-8. PubMed ID: 21349948 [TBL] [Abstract][Full Text] [Related]
22. New Approaches in Locoregional Therapies for Hepatocellular Carcinoma. Memeo R; de Blasi V; Cherkaoui Z; Dehlawi A; De' Angelis N; Piardi T; Sommacale D; Marescaux J; Mutter D; Pessaux P J Gastrointest Cancer; 2016 Sep; 47(3):239-46. PubMed ID: 27270711 [TBL] [Abstract][Full Text] [Related]
23. A new prognostic score can predict survival after hepatocellular carcinoma treatment in a cohort of 1302 Egyptian hepatocellular carcinoma patients. Abdelaziz AO; Shousha HI; Abdelmaksoud AH; Saad Y; Elbaz TM; Soliman ZA; Salah A; Lithy R; Ahmed M; Nabil MM Eur J Gastroenterol Hepatol; 2018 May; 30(5):514-519. PubMed ID: 29465472 [TBL] [Abstract][Full Text] [Related]
25. Safety and effectiveness of chemoembolization with drug-eluting beads for advanced-stage hepatocellular carcinoma. Kalva SP; Pectasides M; Liu R; Rachamreddy N; Surakanti S; Yeddula K; Ganguli S; Wicky S; Blaszkowsky LS; Zhu AX Cardiovasc Intervent Radiol; 2014 Apr; 37(2):381-7. PubMed ID: 23754191 [TBL] [Abstract][Full Text] [Related]
26. Predictors of five-year survival among patients with hepatocellular carcinoma in the United States: an analysis of SEER-Medicare. Zhang X; El-Serag HB; Thrift AP Cancer Causes Control; 2021 Apr; 32(4):317-325. PubMed ID: 33394207 [TBL] [Abstract][Full Text] [Related]
27. Clinical characteristics and outcomes of hepatocellular carcinoma: results from prospective study, from a tertiary referral center in Sri Lanka. Bulathsinhala BKS; Siriwardana RC; Gunetilleke MB; Niriella MA; Dassanayake A Ceylon Med J; 2018 Sep; 63(3):133-138. PubMed ID: 30415518 [TBL] [Abstract][Full Text] [Related]
28. Inequity in end-of-life care for patients with chronic liver disease in England. Woodland H; Buchanan RM; Pring A; Dancox M; McCune A; Forbes K; Verne J Liver Int; 2023 Nov; 43(11):2393-2403. PubMed ID: 37519025 [TBL] [Abstract][Full Text] [Related]
29. Socioeconomic and racial/ethnic disparities in receipt of palliative care among patients with metastatic hepatocellular carcinoma. Alterio RE; Ju MR; Wang SC; Mansour JC; Yopp A; Porembka MR J Surg Oncol; 2021 Dec; 124(8):1365-1372. PubMed ID: 34505295 [TBL] [Abstract][Full Text] [Related]
30. Antiviral Therapy in Patients With Chronic Hepatitis C-related Hepatocellular Carcinoma Responding to Palliative Treatment. Yu JH; Kim JK; Lee KS; Lee JI J Clin Gastroenterol; 2018 Jul; 52(6):557-562. PubMed ID: 28863014 [TBL] [Abstract][Full Text] [Related]
31. Temporal trends in disease presentation and survival of patients with hepatocellular carcinoma: A real-world experience from 1998 to 2015. Kim NG; Nguyen PP; Dang H; Kumari R; Garcia G; Esquivel CO; Nguyen MH Cancer; 2018 Jun; 124(12):2588-2598. PubMed ID: 29624631 [TBL] [Abstract][Full Text] [Related]
32. Epidemiology and survival of hepatocellular carcinoma in the central region of Thailand. Somboon K; Siramolpiwat S; Vilaichone RK Asian Pac J Cancer Prev; 2014; 15(8):3567-70. PubMed ID: 24870758 [TBL] [Abstract][Full Text] [Related]
33. Identifying Core Principles of Palliative Care Consultation in Surgical Patients and Potential Knowledge Gaps for Surgeons. Scally CP; Robinson K; Blumenthaler AN; Bruera E; Badgwell BD J Am Coll Surg; 2020 Jul; 231(1):179-185. PubMed ID: 32311465 [TBL] [Abstract][Full Text] [Related]
34. The retrospective cohort study for survival rate in patients with advanced hepatocellular carcinoma receiving radiotherapy or palliative care. Eun HS; Kim MJ; Kim HJ; Ko KH; Moon HS; Lee ES; Kim SH; Lee HY; Lee BS Korean J Hepatol; 2011 Sep; 17(3):189-98. PubMed ID: 22102385 [TBL] [Abstract][Full Text] [Related]
35. Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: a population-based study. El-Serag HB; Siegel AB; Davila JA; Shaib YH; Cayton-Woody M; McBride R; McGlynn KA J Hepatol; 2006 Jan; 44(1):158-66. PubMed ID: 16290309 [TBL] [Abstract][Full Text] [Related]
36. The effectiveness of locoregional therapies versus supportive care in maintaining survival within the Milan criteria in patients with hepatocellular carcinoma. Dhanasekaran R; Khanna V; Kooby DA; Spivey JR; Parekh S; Knechtle SJ; Carew JD; Kauh JS; Kim HS J Vasc Interv Radiol; 2010 Aug; 21(8):1197-204; quiz 204. PubMed ID: 20656222 [TBL] [Abstract][Full Text] [Related]
37. [Practice of Palliative Care Consultation Proposed by the Emergency Department in Peking Union Medical College Hospital]. Ning XH; Li JY; Dai XY; Liu Q; Shi D; Zhao XX; Li J; Wang L; Ge N; Qu X; DU TK; Zhu HD Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2022 Oct; 44(5):763-767. PubMed ID: 36325771 [TBL] [Abstract][Full Text] [Related]
38. Hospice offers more palliative care but costs less than usual care for terminal geriatric hepatocellular carcinoma patients: a nationwide study. Hwang SJ; Chang HT; Hwang IH; Wu CY; Yang WH; Li CP J Palliat Med; 2013 Jul; 16(7):780-5. PubMed ID: 23790184 [TBL] [Abstract][Full Text] [Related]
39. Liver transplantation, liver resection, and transarterial chemoembolization for hepatocellular carcinoma in cirrhosis: which is the best oncological approach? Sotiropoulos GC; Drühe N; Sgourakis G; Molmenti EP; Beckebaum S; Baba HA; Antoch G; Hilgard P; Radtke A; Saner FH; Nadalin S; Paul A; Malagó M; Broelsch CE; Lang H Dig Dis Sci; 2009 Oct; 54(10):2264-73. PubMed ID: 19057997 [TBL] [Abstract][Full Text] [Related]
40. Palliative treatment in advanced hepatocellular carcinoma: has it made any difference? Paul SB; Manjunatha YC; Acharya SK Trop Gastroenterol; 2009; 30(3):125-34. PubMed ID: 20306740 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]